Secondary Logo

Journal Logo

Advanced Search

Papers from the Women's Health Initiative

  • Updated:   9/27/2021
  • Contains:  59 items
Last Updated: 9/27/2021

Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative

Wild, Robert A.; Hovey, Kathleen M.; Andrews, Christopher; More

Menopause. 28(6):610-618, June 2021.

The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial

Nudy, Matthew; Jiang, Xuezhi; Aragaki, Aaron K.; More

Menopause. 27(11):1265-1273, November 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

Incidence of diabetes according to metabolically healthy or unhealthy normal weight or overweight/obesity in postmenopausal women: the Women's Health Initiative

Cordola Hsu, Amber R.; Ames, Susan L.; Xie, Bin; More

Menopause. 27(6):640-647, June 2020.

Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease

Jiang, Xuezhi; Nudy, Matthew; Aragaki, Aaron K.; More

Menopause. 26(8):841-849, August 2019.

Perceived social support and the risk of cardiovascular disease and all-cause mortality in the Women's Health Initiative Observational Study

Freeborne, Nancy; Simmens, Samuel J.; Manson, JoAnn E.; More

Menopause. 26(7):698-707, July 2019.

Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study

Shufelt, Chrisandra; Bairey Merz, C. Noel; Pettinger, Mary B.; More

Menopause. 25(9):985-991, September 2018.

Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials

Swica, Yael; Warren, Michelle P.; Manson, JoAnn E.; More

Menopause. 25(7):753-761, July 2018.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher A.; More

Menopause. 25(1):11-20, January 2018.

Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher; More

Menopause. 24(10):1145-1153, October 2017.

The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women

Harrington, Laura B.; Blondon, Marc; Cushman, Mary; More

Menopause. 24(4):360-370, April 2017.

Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative

LeBlanc, Erin S.; Kapphahn, Kristopher; Hedlin, Haley; More

Menopause. 24(1):64-72, January 2017.

Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative

Drieling, Rebecca L.; LaCroix, Andrea Z.; Beresford, Shirley A.A.; More

Menopause. 23(11):1168-1175, November 2016.

Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial

Schnatz, Peter F.; Jiang, Xuezhi; Vila-Wright, Sharon; More

Menopause. 21(8):823-833, August 2014.

Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women’s Health Initiative hormone therapy clinical trials

Canonico, Marianne; Plu-Bureau, Geneviève; O’Sullivan, Mary Jo; More

Menopause. 21(3):214-220, March 2014.

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study

Shufelt, Chrisandra L.; Merz, C. Noel Bairey; Prentice, Ross L.; More

Menopause. 21(3):260-266, March 2014.

Coronary heart disease events in the Women’s Health Initiative hormone trials: effect modification by metabolic syndrome: A nested case-control study within the Women’s Health Initiative randomized clinical trials

Wild, Robert A.; Wu, Chunyuan; Curb, J. D.; More

Menopause: The Journal of The North American Menopause Society. 20(3):254-260, March 2013.

Effects of a dietary intervention and weight change on vasomotor symptoms in the Women’s Health Initiative

Kroenke, Candyce H.; Caan, Bette J.; Stefanick, Marcia L.; More

Menopause: The Journal of The North American Menopause Society. 19(9):980-988, September 2012.

Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative

Gass, Margery L.S.; Cochrane, Barbara B.; Larson, Joseph C.; More

Menopause. 18(11):1160-1171, November 2011.

Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse

Pal, Lubna; Hailpern, Susan M.; Santoro, Nanette F.; More

Menopause. 18(9):967-973, September 2011.

Vasomotor symptoms and cardiovascular events in postmenopausal women

Szmuilowicz, Emily D.; Manson, JoAnn E.; Rossouw, Jacques E.; More

Menopause. 18(6):603-610, June 2011.

Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials

Bea, Jennifer W.; Zhao, Qiuhong; Cauley, Jane A.; More

Menopause. 18(1):44-52, January 2011.

Dietary vitamin D and calcium intake and mammographic density in postmenopausal women

Bertone-Johnson, Elizabeth R.; Chlebowski, Rowan T.; Manson, JoAnn E.; More

Menopause. 17(6):1152-1160, November-December 2010.

Vasomotor symptoms and coronary artery calcium in postmenopausal women

Allison, Matthew A.; Manson, JoAnn E.; Aragaki, Aaron; More

Menopause. 17(6):1136-1145, November-December 2010.

Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial

Brunner, Robert L.; Aragaki, Aaron; Barnabei, Vanessa; More

Menopause. 17(5):946-954, September-October 2010.

Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative

Manson, JoAnn E.; Allison, Matthew A.; Carr, J. Jeffrey; More

Menopause. 17(4):683-691, July 2010.

The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women

Edlefsen, Kerstin L.; Jackson, Rebecca D.; Prentice, Ross L.; More

Menopause. 17(3):622-629, May-June 2010.

Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial

Michael, Yvonne L.; Gold, Rachel; Manson, JoAnn E.; More

Menopause. 17(2):295-302, March 2010.

Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study

Allison, Matthew A.; Manson, JoAnn E.; Langer, Robert D.; More

Menopause. 15(4):639-647, July-August 2008.

Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial

Pal, Lubna; Hailpern, Susan M.; Santoro, Nanette F.; More

Menopause. 15(1):59-66, January 2008.

Bone mineral density of American Indian and Alaska Native women compared with non-Hispanic white women: results from the Women's Health Initiative Study

Wampler, Nina S; Chen, Zhao; Jacobsen, Clemma; More

Menopause. 12(5):536-544, September-October 2005.

Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials

Chen, Zhao; Kooperberg, Charles; Pettinger, Mary B.; More

Menopause. 11(3):264-274, May-June 2004.

Show: